Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins

BACKGROUND: It is uncertain whether pharmacological reductions in very‐low‐density lipoproteins (VLDLs), and their component triglyceride and cholesterol could reduce residual risk of atherosclerotic cardiovascular disease (ASCVD) events among individuals in whom low‐density lipoprotein cholesterol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Lawler, Patrick R., Akinkuolie, Akintunde O., Harada, Paulo, Glynn, Robert J., Chasman, Daniel I., Ridker, Paul M, Mora, Samia
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779048/
https://ncbi.nlm.nih.gov/pubmed/29223956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007402
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados